Medical Industry Feature-logo

Medical Industry Feature


Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.

Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.
More Information


United States




Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.




What Sets the Harmony Prenatal Test Apart from Other Cell-Free DNA Screening Tests?

Thanks to rapid advances in genetic testing many cell-free DNA prenatal screening tests are available to you in your patient today. One very important quality metric is called fetal fraction. If fetal fraction is not incorporated in the assessment of a trisomy, then potentially only the maternal portion is analyzed and without the baby, thereby leading to potential false negatives or discordant calls. Professional societies like ACOG and ACMG have included statements and information on the...


Her Diagnosis Matters: What Can You Do to Prevent Misdiagnosis of Vaginitis?

Host: Matt Birnholz, MD Guest: Charlotte A. Gaydos, DrPH, MPH Misdiagnosis of vaginal infections can lead to inappropriate treatment of vaginal infections, prolong symptoms, and increase an affected woman’s risk of developing serious complications. Clinical procedures and traditional diagnostic techniques are insufficient to accurately diagnose the most common types of vaginal infections. Dr. Charlotte A. Gaydos, Professor of the Division of Infectious Diseases at Johns Hopkins...


How Patient Advocacy May Change Rheumatology Treatment & Care

Host: Matt Birnholz, MD Guest: Madelaine A. Feldman, MD, FACR Creating meaningful relationships with your local, state and national legislatures may be easier than you think! As physicians continue to incorporate more services in their offices, they may face local and/or state legislative challenges. Ease this transition by learning more about how to become an advocate and partner with your state and local patient advocacy chapters with host Dr. Matt Birnholz and guest Dr. Mattie...


The Role of Obstetricians and Gynecologists in STI Testing

Guest: Robert Phillips Heine, MD In 2016, there were more than two million cases of chlamydia, gonorrhea, and syphilis reported in the United States. Women and infants, in particular, are at significant risk for long-term consequences of STDs if left undiagnosed or are untreated resulting in serious health consequences, including infertility, life-threatening ectopic pregnancy, and stillbirth in infants. Join Dr. Phillip Heine, Professor of Obstetrics & Gynecology and Pediatrics at...


Advanced Chronic Kidney Disease and Secondary Hyperparathyroidism (HPT): Multidisciplinary Management

Host: John J. Russell, MD Guest: James Wetmore, MD Guest: Michael Germain, MD Guest: Barbara Weis Malone, RN Guest: Mike Spigler Secondary hyperparathyroidism (HPT) refers to the excessive secretion of parathyroid hormone (PTH) by the parathyroid glands in response to decreased renal function and impaired mineral metabolism.1,2 Secondary HPT often occurs in advanced chronic kidney disease (CKD) and may be initially silent and asymptomatic.2 As a result, it is frequently underdiagnosed...


Fetal Medicine Expert Shares Top Tips for Selecting Expanded Genetic Screening Panels

Host: Prathima Setty, MD Guest: Justin M. Brewer, MD There are numerous options for pregnancy screening, making the decision of what type of genetic testing to offer your patients more complex. On today’s program, Dr. Justin Brewer will discuss the most important factors for healthcare professionals to consider when screening their pregnant patients. The focus is on non-invasive prenatal testing and carrier screening panels. Dr. Justin Brewer is a practicing OB/GYN and Maternal-Fetal...


Carrier Screening in your Practice – Is it Time to Expand your View?

Host: John J. Russell, MD Guest: Ronald J. Wapner, MD Guest: Lisa L. Pike-Buchanan, ScM, CGC Traditional carrier screening based on ethnicity has been a standard approach in maternal fetal medicine, but newer expanded carrier screening methods are redefining that standard for couples considering pregnancy or those who are already pregnant. Joining host, Dr. John Russell, is Dr. Ronald Wapner, Professor of Obstetrics & Gynecology and Maternal Fetal Medicine at Columbia University...


Is LDL-C a Reliable Measure in Your At-Risk Patients?

Host: William C. Cromwell, MD, FAHA, FNLA For decades, LDL-C has been the customary measure used by clinicians to estimate LDL quantity. However, LDL-C depends upon cholesterol content within lipoprotein particles and varies widely among individuals, often dependent on metabolic conditions. Dr. William Cromwell, medical director for cardiovascular disease at LabCorp, will address in additional detail why LDL-C may not be the most reliable measure for populations at risk for ASCVD. Click...


Immuno-Oncology: Perspectives on Current Therapies & Future Developments

Guest: Ezra E.W. Cohen, MD Guest: James L. Gulley, MD, PhD, FACP Guest: Omid Hamid, MD Guest: Howard L. Kaufman, MD, FACS Guest: Kunle Odunsi, MD, PhD, FRCOG, FACOG Guest: Mario Sznol, MD This program presents several expert perspectives on the latest immuno-oncology developments and how these advancements are impacting clinical practice. This program has been developed with funding from EMD Serono, Inc. and Merck KGaA, Darmstadt, Germany.


Meet the Authors: Fertility Outcomes After Hysteroscopic Morcellation of Polyps and Fibroids with the MyoSure System

Guest: Serena H. Chen, MD Guest: Michael D. Scheiber, MD, MPH, FACOG Join Dr. Serena Chen, Director of Reproductive Medicine at the Institute for Reproductive Medicine and Science at Saint Barnabas in New Jersey, and Dr. Michael Scheiber, Director of Reproductive Research and Co-Director of In Vitro Fertilization Services at the Institute for Reproductive Health in Cincinnati, Ohio, as they discuss fertility outcomes after hysteroscopic procedures. This activity will address the clinical...


Key Allergy Highlights from AAAAI 2017: Celebrating Past Discoveries, Current Guidelines, & Future Developments

Host: Matt Birnholz, MD This program was recorded at the American Academy of Allergy, Asthma & Immunology (AAAAI) Conference in Atlanta, Georgia and provides perspectives from key opinion leaders in the fields of allergy, asthma, and immunology. Faculty discuss the 50-year anniversary of the discovery of IgE, including the history behind this groundbreaking discovery and current clinical applications. Faculty will also discuss the latest allergy guideline updates, such as the Peanut...


How Office-Based Gynecological Procedures are Changing Patient Care

Host: Barnett Mennen, MD Guest: Francis Gardner Live from the floor of AAGL 2016, host Dr. Barry Mennen is joined by Mr. Francis Gardner, former Clinical Director and Senior Consultant for Gynecology and Gynecological Oncology at the Queen Alexandra Hospital in Portsmouth, England. Mr. Gardner shares his insights on office-based gynecological procedures, and the use of minimal-access surgical techniques to improve postoperative patient recovery and patient care. Click here for more...


PLLA Dermal Filler: Injection Techniques, Patient Selections, and Safety Considerations

Dr. Becky Fitzgerald, a dermatologist in private practice in Los Angeles, CA and on the clinical faculty at UCLA, and Dr. Sabrina Fabi, dermatologist, assistant clinical professor at the University of California, San Diego, and associate at Cosmetic Laser Dermatology, discuss Poly-L-lactid Acid (PLLA) injections and how to best employ this unique product cosmetically for patients.


A Look at a GLP-1 Treatment Option for Adult Patients with Type 2 Diabetes

Host: John J. Russell, MD Guest: Ralph A. DeFronzo, MD Leading Endocrinologist, Dr. Ralph A. DeFronzo joins host Dr. John Russell to discuss, "A Look at a GLP-1 Treatment Option for Adult Patients with Type 2 Diabetes" brought to you by AstraZeneca. Dr. DeFronzo will review BYETTA® (exenatide) injection, prescribing and usage guidelines; results of the 4B Study; and, potential risks and benefits of BYETTA. Dr. DeFronzo is Professor of Medicine, the Chief of the Diabetes Division at the...


The Role of Bisphosphonates in Osteoporosis Therapy Today

Host: John J. Russell, MD Guest: Sol Epstein, MD, FRCP, FACP Bisphosphonates were the first class of drugs to be approved for the treatment of osteoporosis, and they remain the foundation of treatment to this day. What is it about this class that makes it so efficacious—and what are some of the pitfalls? Host Dr. John Russell welcomes Sol Epstein, MD, FRCP, FACP, professor of medicine and geriatrics at Mt. Sinai School of Medicine in New York, and adjunct professor of medicine at the...


Why We Need To Improve Our Diagnosis and Treatment of Osteoporosis

Host: John J. Russell, MD Guest: Sol Epstein, MD, FRCP, FACP Osteoporotic fractures are among the most prevalent postmenopausal health conditions. In the US alone, more than 1.5 million fractures, including 700,000 vertebral and 300,000 hip fractures, occur in men and women every year. Host Dr. John Russell welcomes Dr. Sol Epstein, an osteoporosis expert who will discuss strategies for dealing with this major public health issue. Dr. Epstein is professor of medicine and geriatrics at...